Ameliorative Role of β‐Caryophyllene on Antioxidant Biomarkers in a Paroxetine‐Induced Model of Male Sexual Dysfunction
Basic & Clinical Pharmacology & Toxicology · 2025-03 · 136 (3)
DOI: 10.1111/bcpt.70010 ↗At a glance
Journal article in Basic & Clinical Pharmacology & Toxicology, published online on 2025-02-17. Written by Elijah Oluwatosin Olopade and 5 co-authors. Institution: Department of Biochemistry, Adeleke University, Ede, Osun State, Nigeria. Major MEDLINE topics: Antioxidants, Paroxetine, Erectile Dysfunction, Sesquiterpenes. Cited 7 times so far (Crossref); 38 references. The full text is freely available (open access, CC BY-NC 4.0).
Abstract (original language)
Male sexual dysfunction, characterised by reduced libido, ejaculatory issues and erectile dysfunction, often results from oxidative stress and enzymatic imbalance, notably involving phosphodiesterase type 5 (PDE5) and nitric oxide synthase (NOS). This study explores the therapeutic potential of β‐caryophyllene (β‐CBP), a sesquiterpene with antioxidant and anti‐inflammatory properties, in mitigating paroxetine‐induced sexual dysfunction in rats. Male Wistar rats were divided into nine treatment groups: control, paroxetine (20 mg/kg/day), sildenafil (20 mg/kg/day), β‐CBP (10 mg/kg/day), β‐CBP (20 mg/kg/day), paroxetine with β‐CBP (10 mg/kg), paroxetine with β‐CBP (20 mg/kg), paroxetine with sildenafil and β‐CBP with sildenafil. Sexual behavioural assays were evaluated, along with oxidative stress markers, including superoxide dismutase (SOD) and catalase (CAT) activity in penile tissue, assessed using spectrophotometric analysis. CB2 receptor expression was significantly increased in β‐CBP‐treated groups, suggesting enhanced cannabinoid receptor‐mediated signalling, which may be linked to improved erectile function. The effects were dose‐dependent, with the 20 mg/kg β‐CBP group displaying the most significant improvements. Additionally, β‐CBP restored antioxidant enzyme activities, including SOD, CAT and reduced glutathione (GSH) levels in penile tissue, effectively reducing oxidative stress. β‐CBP shows promise as a therapeutic agent for male sexual dysfunction by enhancing antioxidative capacity and modulating enzymatic balance.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Biochemistry, Adeleke University, Ede, Osun State, Nigeria.
- Functional Foods and Nutraceutical Unit, Department of Biochemistry, Federal University of Technology, Akure, Ondo, Nigeria.
- School of Public Health and Interdisciplinary Studies, Auckland University of Technology, Auckland, New Zealand.
- College of Agriculture Food and Natural Resources, University of Missouri, Columbia, Missouri, USA.
- Augusta University, Augusta, Georgia, USA.
ORCID profiles: Jude Oluwapelumi Alao
Cite
APA
Olopade, E. O., Adefegha, S. A., Alao, J. O., Adepoju, A. E., Fakayode, A. E., & Oboh, G. (2025). Ameliorative Role of β‐Caryophyllene on Antioxidant Biomarkers in a Paroxetine‐Induced Model of Male Sexual Dysfunction. Basic & Clinical Pharmacology & Toxicology, 136(3). https://doi.org/10.1111/bcpt.70010
Vancouver
Olopade EO, Adefegha SA, Alao JO, Adepoju AE, Fakayode AE, Oboh G. Ameliorative Role of β‐Caryophyllene on Antioxidant Biomarkers in a Paroxetine‐Induced Model of Male Sexual Dysfunction. Basic & Clinical Pharmacology & Toxicology. 2025;136(3). doi:10.1111/bcpt.70010
BibTeX
@article{Olopade2025,
author = {Olopade, Elijah Oluwatosin and Adefegha, Stephen Adeniyi and Alao, Jude Oluwapelumi and Adepoju, Ayodeji Emmanuel and Fakayode, Aderonke Elizabeth and Oboh, Ganiyu},
title = {Ameliorative Role of β‐Caryophyllene on Antioxidant Biomarkers in a Paroxetine‐Induced Model of Male Sexual Dysfunction},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2025},
volume = {136},
number = {3},
doi = {10.1111/bcpt.70010}
}
EUVIMED